198 related articles for article (PubMed ID: 29157555)
1. [Systemic therapy for advanced endometrial cancer].
Pautier P; Pommeret F
Bull Cancer; 2017 Dec; 104(12):1046-1053. PubMed ID: 29157555
[TBL] [Abstract][Full Text] [Related]
2. [Systemic therapy for advanced endometrial cancer].
Tazi Y; Pautier P; Lhommé C
Bull Cancer; 2012 Jan; 99(1):93-7. PubMed ID: 22236886
[TBL] [Abstract][Full Text] [Related]
3. Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments.
Lheureux S; Oza AM
Eur J Cancer; 2016 May; 59():99-108. PubMed ID: 27017291
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in systemic therapy for advanced endometrial cancer.
Tsoref D; Oza AM
Curr Opin Oncol; 2011 Sep; 23(5):494-500. PubMed ID: 21673575
[TBL] [Abstract][Full Text] [Related]
5. Medical therapy of endometrial cancer: current status and promising novel treatments.
Hill EK; Dizon DS
Drugs; 2012 Mar; 72(5):705-13. PubMed ID: 22439671
[TBL] [Abstract][Full Text] [Related]
6. Developments in the systemic treatment of endometrial cancer.
Mountzios G; Pectasides D; Bournakis E; Pectasides E; Bozas G; Dimopoulos MA; Papadimitriou CA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):278-92. PubMed ID: 20833559
[TBL] [Abstract][Full Text] [Related]
7. Update on the chemotherapeutic management of endometrial cancer.
Bregar A; Robison K; Dizon DS
Clin Adv Hematol Oncol; 2014 Oct; 12(10):659-65. PubMed ID: 25658891
[TBL] [Abstract][Full Text] [Related]
8. New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
Rodriguez-Freixinos V; Karakasis K; Oza AM
Curr Oncol Rep; 2016 Apr; 18(4):23. PubMed ID: 26922329
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options for endometrial cancer.
Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
[TBL] [Abstract][Full Text] [Related]
10. Current treatment of metastatic endometrial cancer.
Temkin SM; Fleming G
Cancer Control; 2009 Jan; 16(1):38-45. PubMed ID: 19078928
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
Karagol H; Saip P; Uygun K; Kucucuk S; Aydiner A; Topuz E
Med Oncol; 2006; 23(4):543-8. PubMed ID: 17303913
[TBL] [Abstract][Full Text] [Related]
12. Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
Papa A; Zaccarelli E; Caruso D; Vici P; Benedetti Panici P; Tomao F
Expert Opin Investig Drugs; 2016; 25(1):31-49. PubMed ID: 26560489
[TBL] [Abstract][Full Text] [Related]
13. Management Strategies for Recurrent Endometrial Cancer.
Connor EV; Rose PG
Expert Rev Anticancer Ther; 2018 Sep; 18(9):873-885. PubMed ID: 29972650
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy in metastatic or recurrent endometrial cancer.
Pectasides D; Pectasides E; Economopoulos T
Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
[TBL] [Abstract][Full Text] [Related]
15. [Hormonal therapy and chemotherapy of endometrial cancer].
Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapy of endometrial stromal sarcoma.
Reich O; Regauer S
Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
[TBL] [Abstract][Full Text] [Related]
17. [The validity of chemotherapy in the treatment of endometrial cancer].
Fehr MK; Streich MS
Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):34-8. PubMed ID: 16452818
[TBL] [Abstract][Full Text] [Related]
18. [Combination of stereotactic irradiation and chemotherapy or targeted therapies: state of the art and preliminary recommendations].
Thariat J; Kirova Y; Milano G; Mornex F
Cancer Radiother; 2014; 18(4):270-9. PubMed ID: 25053603
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
Deppe G; Baumann P; Munkarah A
Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
[TBL] [Abstract][Full Text] [Related]
20. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
